Última Hora: "Sonae coloca retalho alimentar em bolsa até ao fim do ano - Expresso" Wed, 19 Sep 2018 08:50:00 GMT    "Transferências imediatas. O seu ordenado vai passar a chegar à conta um dia mais cedo - Observador" Wed, 19 Sep 2018 15:08:42 GMT    "Bruxelas exige à Ryanair que mostre ?responsabilidade social? - TVI24" Wed, 19 Sep 2018 17:43:00 GMT    "Worten investe 7 milhões no novo negócio digital Marketplace - Jornal de Negócios - Portugal" Wed, 19 Sep 2018 16:23:00 GMT    "Plataforma cívica e associações agendam protesto contra aeroporto no Montijo - Dinheiro Vivo" Wed, 19 Sep 2018 18:34:00 GMT    "Governo desafia PSD para consensos nos investimentos, mas só ouve críticas - Expresso" Wed, 19 Sep 2018 18:24:00 GMT    "Pilotos da Ryanair pedem nova liderança aos acionistas - Correio da Manhã" Wed, 19 Sep 2018 17:22:54 GMT    "Espanha suspende impostos sobre as elétricas para travar escalada dos preços - Observador" Wed, 19 Sep 2018 19:31:51 GMT   "" Wed, 19 Sep 2018 20:35:43 GMT    "Lei 'Uber' foi ?aprovada por 80% dos deputados?, recorda Uber Portugal - Jornal Económico" Wed, 19 Sep 2018 19:00:46 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Procure análises técnicas no nosso fórum aqui: Análises Técnicas
Nota: Os dados após 2018-09-14 são ainda temporários e poderão por isso ter o valor de Abertura errado até nova actualização...
Mudar para Gráfico Estático de SCHERING PLOUGH C

Queda de
--10.00 (+0.97%) SCHERING PLOUGH C - [Ticker: SGP]Gráfico SCHERING PLOUGH C  Notícias SCHERING PLOUGH C  Download de Históricos Metastock SCHERING PLOUGH C e Outros  Análise Técnica SCHERING PLOUGH C  
Última Trade368,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade2018-09-14 - 00:00:00Price-Target 1 Ano0,000
Variação--10.00 (+0.97%)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura378,000PER0,00%
Máximo378,000Pagamento Dividendo
Mínimo368,000Data Ex-Dividendo
Fecho Anterior378,000Yield
Volume420Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.

 Notícias sobre SCHERING PLOUGH C [SGP]:   (ordenadas por relevância)

Array BioPharma Names Carrie S. Cox Chairman of its Board of ...
Markets Insider
Before joining Schering-Plough, Ms. Cox served as Executive Vice President and President of Pharmacia's Global Prescription Business, Senior Vice President of Pharmacia & Upjohn's Global Prescription Business, and as Vice President of Women's ...

e mais »

theperfectinvestor.com

Global Interferon Biosimilar Market Outlook 2018-PROBIOMED ...
theperfectinvestor.com
... offer a clear viewpoint of the Interferon Biosimilar market. The dominant companies Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio, Amgen, Bayer, Schering Plough, Merck are additionally ...

e mais »

Reuters

Keytruda sales power Merck to quarterly beat
Reuters
(Reuters) - Drugmaker Merck & Co (MRK.N) reported better-than-expected first-quarter earnings on Tuesday, helped by a more than 150 percent rise in sales of blockbuster cancer drug Keytruda.


2018-2025 Interferon Biosimilar Market by Raw Materials, Labour ...
Expert Herald (press release) (blog)
Interferon Biosimilar Market Report contribute in analysing the growth factors in upcoming years. This report provides market overview which includes Product Category, Applications, Manufactures. This report research delivers region and country level ...


The Economist

A pharmaceutical firm bets big on a cancer drug
The Economist
Merck's merger with another pharma firm, Schering-Plough, in 2009, had brought it an obscure new cancer drug. At first Merck's scientists were unimpressed and relegated the drug to a list of assets to be licensed out. There was widespread scepticism at ...


The Pharmaceutical Journal

Hepatitis C: tackling the silent killer
The Pharmaceutical Journal
1997: The first alpha interferon, Schering-Plough's Intron A (interferon alpha-2B), is approved for treatment of hepatitis C in the UK. 1999: European blood services begin screening blood with nucleic acid amplification testing (NAT), because it ...


Merck, Schering-Plough set to complete merger
Reuters
NEW YORK (Reuters) - Merck & Co (MRK.N) and Schering-Plough Corp SGP.N said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. Pfizer Inc (PFE.


Motif Bio Appoints Stephanie Noviello, MD, MPH as Vice President ...
GlobeNewswire (press release)
In this position, she served as clinical lead for the hepatitis B and C and HIV portfolios. She previously worked at Schering-Plough Research Institute as a Director in Hepatology. Prior to working in industry, she was an Epidemic Intelligence Service ...


Neue Presse

USA: Deutsche Firma soll Gift für Hinrichtungen geliefert haben
Neue Presse
Daten des US-Zolls zufolge lieferte VET Pharma die Medikamente an ein US-Schwesterunternehmen, die Intervet Schering-Plough Animal Health. Beide Firmen gehören zum US-Pharmariesen Merck Sharp & Dohme (MSD). Weitere Lieferungen sollen nach ...

e mais »

Business Wire (press release)

Science Exchange Adds Allergan EVP & Chief R&D Officer David ...
Business Wire (press release)
PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, Inc. announced today that C. David Nicholson, Ph.D., EVP and Chief R&D Officer at Allergan, has joined the Science Exchange Board of Directors. Dr. Nicholson's experience includes over forty ...

e mais »

Forbes

What You Should Know About Ken Frazier, The CEO Who Just Quit ...
Forbes
Kenneth C. Frazier, the chairman and chief executive of the U.S. drug maker Merck, resigned from President Donald Trump's American Manufacturing Council on Monday morning, saying in a statement, ?As CEO of Merck and as a matter of personal conscience ...

e mais »

In Vivo

Bristol/Medarex: A Transformational Acquisition Rooted In ...
In Vivo
Bristol's $2.4 billion buyout of Medarex in 2009 yielded value equivalent or greater to that realized in larger M&A transactions signed that year, such as Pfizer/Wyeth, Merck/Schering-Plough and Roche/Genentech. The deal made BMS a leader in ...


CNNMoney.com

Merck and Schering-Plough in $41B merger
CNNMoney.com
... and Swiss drugmaker Roche Holding AG continues to pursue a $40 billion hostile bid of Genentech Inc. (DNA). Shares of Merck (MRK, Fortune 500) fell about 11% and Schering-Plough (SGP, Fortune 500) shares were up about 11% in premarket trading.
Merck to Buy Schering-Plough for $41.1 BillionNew York Times
Merck to Buy Rival for $41 BillionWall Street Journal

todos os 2.448 artigos de notícias »

GlobeNewswire (press release)

Esperion Announces the Appointment of Jeffrey Berkowitz to Board ...
GlobeNewswire (press release)
We are confident Jeff will provide important contributions to help us deliver on the promise of bringing our complementary, oral LDL-C lowering therapies to the millions of patients who are inadequately treated with, or unable to gain access to ...

e mais »

https://farmweek.com/about-us/

Hampshire Down breeders annual awards evening
https://farmweek.com/about-us/
They were awarded the Moneycarragh Trophy for Best Individual Male, Anniversary Crystal Rose Bowl for Best Female Show Team and the Schering Plough Trophy for team having gained most points at three shows. Peter was a little shocked and very ...

Para mais notícias sobre SCHERING PLOUGH C clique aqui:
Notícias de SCHERING PLOUGH C 


Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters